http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106729577-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8945 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-486 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9068 |
| filingDate | 2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106729577-B |
| titleOfInvention | Traditional Chinese medicine composition for treating rheumatism and preparation method thereof |
| abstract | A traditional Chinese medicine composition for treating rheumatism and its preparation method, the active prescription in the traditional Chinese medicine composition is composed of (by weight parts) Ningpo Yam rhizome extract 7-10, caulis Spatholobi extract 6-8, and Zingiberis rhizoma extract 2-5. The preparation method comprises the following steps: extracting rhizoma Discoreae Nipponicae and Zingiberis rhizoma with ethanol under reflux, adsorbing with resin, eluting, concentrating, and drying the eluate. Decocting caulis Spatholobi in water, and concentrating and drying to obtain water extractive solution. Mixing the extracts, adding medicinal adjuvants, and making into conventional dosage form to obtain the Chinese medicinal composition for treating rheumatism. The invention has the beneficial effects that: the active components are used as the medicine in the form of the extract of the active components, the active parts are complete, the compatibility of the active components and the regulation of the component proportion are clear, and the material basis is clear. Corresponding pharmacodynamic evaluation is carried out aiming at the migratory arthralgia in the rheumatic arthralgia, the action mechanism is clear, and the curative effect is obviously improved. |
| priorityDate | 2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.